Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page otherwise continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a transition to using “Super Intelligence” in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T14:32:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:46:35.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:07:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message with a Home link instead of study information.
    Difference
    0.5%
    Check dated 2026-10-04T15:58:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Access to the NCT02614066 study page now displays a 403 Forbidden error, replacing the usual trial details with an error screen. This indicates a site access issue rather than an update to the study content.
    Difference
    21%
    Check dated 2026-09-20T15:51:44.000Z thumbnail image

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.